In our current study, we uncovered that the pre-BCG tumor tissues of responders were presented with higher densities of CD8+PD-1+ as well as non-Treg CD4+FOXP3- T cells comparing with those of the non-responders (Figures 5C, D). The gene discussed is CD8A; the disease is neoplasm.